Independent broker researchIssue 027Vol. IV
027Vol. IVJuly 7, 2026
— independent broker research —

Safety research

Dukascopy safety, funds protection and entity checks

Use this page as a focused research note for Dukascopy. It summarizes current InvestorTrip broker database fields and shows what to verify before opening or funding an account.

Funds note

Present

Current database field; verify scheme scope directly.

Regulator labels

3

Labels recorded in the current broker row.

Notice context

None shown

Resolve notices before funding an account.

Dukascopy safety fields

These fields help structure safety research. They do not prove that an account is protected, available or suitable for any country.

Funds protection note
Dukascopy is authorized by FINMA to operate under Swiss financial laws. It also complies with EU regulations and operates within the legal framework in Latvia and other jurisdictions. Client funds are kept in segregated accounts and protected by Swiss banking laws. Each client is eligible for up to CHF 100,000 in deposit insurance.
Regulator labels
FINMA, FCMC, JFSA
Editorial notice
None shown

Dukascopy safety labels to verify

Match each label to the exact legal entity and account documents before relying on it.

  • FINMA
  • FCMC
  • JFSA

Read the broker safety methodology with the full review, regulator register, account agreement and current risk disclosures.

Safety checklist

  1. 1Identify the exact legal entity that would open your account.
  2. 2Verify that entity in the relevant public regulator register.
  3. 3Check whether any compensation scheme or funds-protection language applies to your country, client category and product.
  4. 4Confirm segregation, custody, negative-balance and complaint-path claims from current broker documents.
  5. 5Resolve any editorial notice, warning or license-history context before depositing.

Continue researching this broker